Works about MULTIPLE myeloma


Results: 5000
    1
    2
    3
    4
    5

    Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 6, p. 1730, doi. 10.1111/bjh.20062
    By:
    • Pasvolsky, Oren;
    • Abid, Muhammad Bilal;
    • Milton, Denái R.;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Saini, Neeraj;
    • Jatoi, Asiya;
    • Khan, Hina N.;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Siddiqui, Umer;
    • Aljawai, Yosra;
    • Kebriaei, Partow;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Gaballa, Mahmoud R.;
    • Thomas, Sheeba K.
    Publication type:
    Article
    6

    Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real‐world data.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 6, p. 1642, doi. 10.1111/bjh.20050
    By:
    • Biran, Noa;
    • Dhakal, Binod;
    • Niesvizky, Ruben;
    • Lentzsch, Suzanne;
    • Bhutani, Divaya;
    • McKay, John T.;
    • Vesole, David H.;
    • Nooka, Ajay;
    • Paul, Barry;
    • Hari, Parameswaran N.;
    • D'Ambrosi, Silvia;
    • Kuiper, Rowan;
    • van Vliet, Martin;
    • Siegel, David;
    • Usmani, Saad Z.;
    • van Rhee, Frits
    Publication type:
    Article
    7

    PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance.

    Published in:
    Science Immunology, 2025, v. 10, n. 108, p. 1, doi. 10.1126/sciimmunol.adn4302
    By:
    • Zhong, Cheng;
    • Wang, Lixiang;
    • Liu, Yujia;
    • Wang, Xinyu;
    • Xia, Zijin;
    • Li, Yiyi;
    • Zhang, Yao;
    • Liao, Jing;
    • Wang, Xianmiao;
    • Liao, Chenyang;
    • Huang, Chunliu;
    • Wang, Xiumei;
    • Mao, Chengzhou;
    • Feng, Yongyi;
    • Luo, Congzhou;
    • Mai, Wenhao;
    • Song, Hongrui;
    • Sheng, Yue;
    • He, Yingyi;
    • Wei, Xiaolei
    Publication type:
    Article
    8
    9
    11

    Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial.

    Published in:
    Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00358-x
    By:
    • Leypoldt, Lisa B.;
    • Guo, Linlin;
    • Besemer, Britta;
    • Hänel, Mathias;
    • Raab, Marc-S.;
    • Mann, Christoph;
    • Michel, Christian S.;
    • Reinhardt, Hans Christian;
    • Blau, Igor Wolfgang;
    • Görner, Martin;
    • Ko, Yon-Dschun;
    • de Wit, Maike;
    • Salwender, Hans;
    • Scheid, Christof;
    • Graeven, Ullrich;
    • Peceny, Rudolf;
    • Staib, Peter;
    • Dieing, Annette;
    • Goldschmidt, Hartmut;
    • Bokemeyer, Carsten
    Publication type:
    Article
    12

    Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60980-2
    By:
    • Atanackovic, Djordje;
    • Luetkens, Tim;
    • Schneider, Dina;
    • Hu, Peirong;
    • Wang, Xu;
    • Shetty, Amol C.;
    • Tallon, Luke;
    • Patel, Imari;
    • Singh, Rohan;
    • Gebru, Etse;
    • Mulatu, Rediet;
    • Omili, Destiny;
    • Yamoah, Daniel;
    • Fan, Xiaoxuan;
    • Matsangos, Aerielle;
    • Lesho, Patricia;
    • Dietze, Kenneth A.;
    • Fromowitz, Ariel A.;
    • Hankey, Kim G.;
    • Dahiya, Saurabh
    Publication type:
    Article
    14
    15
    16

    Novel Interpretation Criteria (Italian Myeloma Criteria for Positron Emission Tomography Use) Its Prognostic Significance for Fluorodeoxyglucose Labeled with Fluorine-18 Positron Emission Tomography / Computed Tomography in Multiple Myeloma.

    Published in:
    Egyptian Journal of Hospital Medicine, 2025, v. 99, n. 1, p. 1731, doi. 10.21608/ejhm.2025.424108
    By:
    • Yousef, Ahmed Farid;
    • Ahmed Amer, Ayman Fathy;
    • Mahmoud Elgendy, Wassem Mohamed;
    • Torky, Ahmed Abdallah;
    • Hassan Elsawy, Lamiaa Mahmoud
    Publication type:
    Article
    17
    18
    19
    20

    Cost‐Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma.

    Published in:
    Journal of Clinical Apheresis, 2025, v. 40, n. 3, p. 1, doi. 10.1002/jca.70026
    By:
    • Passos, Roselene Mesquita Augusto;
    • Marcolino, Miriam Allein Zago;
    • Passos, Júlia Augusto;
    • Calsavara, Vinicius Fernando;
    • de Lourdes Martins Perobelli, Leila;
    • Campolina, Alessandro Gonçalves;
    • de Almeida‐Neto, Cesar
    Publication type:
    Article
    21
    22
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous Transplantation.

    Published in:
    Onco, 2025, v. 5, n. 2, p. 21, doi. 10.3390/onco5020021
    By:
    • Spiliopoulou, Polyxeni;
    • Rousakis, Pantelis;
    • Panteli, Chrysanthi;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Terpos, Evangelos;
    • Myrianthopoulos, Vassilios;
    • Gavriatopoulou, Maria;
    • Tsitsilonis, Ourania E.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios;
    • Terzis, Gerasimos
    Publication type:
    Article
    35
    36

    Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18 , 595

    Published in:
    2025
    By:
    • Sgherza, Nicola;
    • Battisti, Olga;
    • Curci, Paola;
    • Conticello, Concetta;
    • Palmieri, Salvatore;
    • Derudas, Daniele;
    • Germano, Candida;
    • Martino, Enrica Antonia;
    • Mele, Giuseppe;
    • Della Pepa, Roberta;
    • Fazio, Francesca;
    • Mele, Anna;
    • Rossini, Bernardo;
    • Palazzo, Giulia;
    • Roccotelli, Daniela;
    • Rasola, Simona;
    • Petrucci, Maria Teresa;
    • Pastore, Domenico;
    • Tarantini, Giuseppe;
    • Pane, Fabrizio
    Publication type:
    Correction Notice
    37
    39

    Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.

    Published in:
    2021
    By:
    • Jackson, Graham H.;
    • Pawlyn, Charlotte;
    • Cairns, David A.;
    • de Tute, Ruth M.;
    • Hockaday, Anna;
    • Collett, Corinne;
    • Jones, John R.;
    • Kishore, Bhuvan;
    • Garg, Mamta;
    • Williams, Cathy D.;
    • Karunanithi, Kamaraj;
    • Lindsay, Jindriska;
    • Rocci, Alberto;
    • Snowden, John A.;
    • Jenner, Matthew W.;
    • Cook, Gordon;
    • Russell, Nigel H.;
    • Drayson, Mark T.;
    • Gregory, Walter M.;
    • Kaiser, Martin F.
    Publication type:
    journal article
    40

    Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.

    Published in:
    2020
    By:
    • Danziger, Samuel A.;
    • McConnell, Mark;
    • Gockley, Jake;
    • Young, Mary H.;
    • Rosenthal, Adam;
    • Schmitz, Frank;
    • Reiss, David J.;
    • Farmer, Phil;
    • Alapat, Daisy V.;
    • Singh, Amrit;
    • Ashby, Cody;
    • Bauer, Michael;
    • Ren, Yan;
    • Smith, Kelsie;
    • Couto, Suzana S.;
    • van Rhee, Frits;
    • Davies, Faith;
    • Zangari, Maurizio;
    • Petty, Nathan;
    • Orlowski, Robert Z.
    Publication type:
    journal article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50